76 related articles for article (PubMed ID: 19839793)
1. Amphotericin B microspheres: a therapeutic approach to minimize toxicity while maintaining antifungal efficacy.
Angra PK; Oettinger C; Balakrishna Pai S; D'Souza MJ
J Microencapsul; 2009 Nov; 26(7):580-7. PubMed ID: 19839793
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and biodistribution studies of amphotericin B microspheres.
Angra PK; Siddig A; Nettey H; Desai N; Oettinger C; D'Souza MJ
J Microencapsul; 2009 Nov; 26(7):627-34. PubMed ID: 19839798
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
[TBL] [Abstract][Full Text] [Related]
4. Hemolytic and antifungal activity of liposome-entrapped amphotericin B prepared by the precipitation method.
Kim JC; Lee EO; Kim JY; Bae SK; Choi TB; Kim JD
Pharm Dev Technol; 1997 Aug; 2(3):275-84. PubMed ID: 9552455
[TBL] [Abstract][Full Text] [Related]
5. Determination of the physical state of drug in microcapsule and microsphere formulations.
Dash AK
J Microencapsul; 1997; 14(1):101-12. PubMed ID: 8994079
[TBL] [Abstract][Full Text] [Related]
6. Effect of aggregation state on the toxicity of different amphotericin B preparations.
Espada R; Valdespina S; Alfonso C; Rivas G; Ballesteros MP; Torrado JJ
Int J Pharm; 2008 Sep; 361(1-2):64-9. PubMed ID: 18599228
[TBL] [Abstract][Full Text] [Related]
7. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
[TBL] [Abstract][Full Text] [Related]
8. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
9. Amphotericin B lipid preparations: what are the differences?
Adler-Moore JP; Proffitt RT
Clin Microbiol Infect; 2008 May; 14 Suppl 4():25-36. PubMed ID: 18430127
[TBL] [Abstract][Full Text] [Related]
10. Novel graft PLLA-based copolymers: potential of their application to particle technology.
Calandrelli L; De Rosa G; Errico ME; La Rotonda MI; Laurienzo P; Malinconico M; Oliva A; Quaglia F
J Biomed Mater Res; 2002 Nov; 62(2):244-53. PubMed ID: 12209945
[TBL] [Abstract][Full Text] [Related]
11. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
Jelvehgari M; Atapour F; Nokhodchi A
Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a new formulation of amphotericin B in murine disseminated infections by Candida glabrata or Candida tropicalis.
Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
Int J Antimicrob Agents; 2009 Dec; 34(6):566-9. PubMed ID: 19733036
[TBL] [Abstract][Full Text] [Related]
14. Liposomal amphotericin B for the treatment of severe fungal infection.
Michaud D
Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
[TBL] [Abstract][Full Text] [Related]
15. Preparation and In vitro Evaluation of Efficacy and Toxicity of Polysorbate 80-coated Bovine Serum Albumin Nanoparticles containing Amphotericin B.
Pedroso LS; Khalil NM; Mainardes RM
Curr Drug Deliv; 2018; 15(7):1055-1063. PubMed ID: 29629661
[TBL] [Abstract][Full Text] [Related]
16. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
17. Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate.
Albertini B; Passerini N; Di Sabatino M; Vitali B; Brigidi P; Rodriguez L
Eur J Pharm Sci; 2009 Mar; 36(4-5):591-601. PubMed ID: 19150403
[TBL] [Abstract][Full Text] [Related]
18. Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres.
Gayakwad SG; Bejugam NK; Akhavein N; Uddin NA; Oettinger CE; D'Souza MJ
J Microencapsul; 2009 Dec; 26(8):692-700. PubMed ID: 19888878
[TBL] [Abstract][Full Text] [Related]
19. Study of the toxicity of a new lipid complex formulation of amphotericin B.
Larabi M; Pages N; Pons F; Appel M; Gulik A; Schlatter J; Bouvet S; Barratt G
J Antimicrob Chemother; 2004 Jan; 53(1):81-8. PubMed ID: 14657087
[TBL] [Abstract][Full Text] [Related]
20. What is the current and future status of conventional amphotericin B?
Kleinberg M
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]